The Europe diabetic assays market was valued at USD 1,005.40 million in 2022 and is projected to reach USD 1,418.90 million by 2030. The market is expected to grow at a compound annual growth rate (CAGR) of 4.4% during the forecast period from 2023 to 2030. Germany stands out as the leading country in the region, driven by advanced healthcare...